ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
CP003960 |
|
143-67-9 |
Vinblastine sulfate - 99% |
0 | C46H58N4O9.H2SO4 | |
CP003228 |
|
154-21-2 |
Lincomycin - 98% |
0 | C18H34N2O6S | |
CP005880 |
|
76824-35-6 |
Famotidine - 99% |
0 | C8H15N7O2S3 | |
CP001222 |
|
9041-93-4 |
Bleomycin sulfate - 1760iu/mg |
0 | C55H84N17O21S3.HSO4 | |
CP005457 |
|
8005-02-5 |
Solvent Black 7 - 99% |
0 | C14H22N2O4S | |
CP008486 |
|
154-17-6 |
2-Deoxy-D-glucose - 99.2% |
0 | C6H12O5 | |
CP002111 |
|
85650-52-8 |
Mirtazapine - 99% |
0 | C17H19N3 | |
CP006502 |
|
81732-46-9 |
Bambuterol hydrochloride - 99% |
0 | C18H29N3O5.HCL | |
CP002661 |
|
150-86-7 |
Phytol - 98% |
0 | C20H40O | |
CP003264 |
|
119413-54-6 |
Topotecan Hydrochloride - 98% |
0 | C23H23N3O5.HCL | |
CP002607 |
|
50-65-7 |
Niclosamide - 99% |
0 | C13H8Cl2N2O4 | |
CP003766 |
|
109581-93-3 |
Tacrolimus monohydrate - 99% |
0 | C44H69NO12.H2O | |
CP007874 |
|
130-40-5 |
Riboflavin sodium phosphate;Riboflavin 5'-Monophosphate Sodium Salt - 73-79% |
0 | C17H20N4NAO9P.2H2O | |
CP005113 |
|
1184-16-3 |
Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), 5'→5'-ester with 3-(aminocarbonyl)-1-β-d-ribofuranosylpyridinium hydroxide, inner salt, monosodium salt - 98% |
0 | C21H28N7O17P3.NA | |
CP005026 |
|
75621-03-3 |
3-[(3-Cholanidopropyl)dimethylammonio]-1-propanesulfonate - 99% |
0 | C32H58N2O7S | |
CP005274 |
|
97-41-6 |
Ethyl chrysanthemumate - 98% |
0 | C12H20O2 | |
CP000004 |
|
139404-48-1 |
Tiotropium bromide - 99% |
0 | C19H22BrNO4S2.H2O | |
CP007241 |
|
51446-62-9 |
(2S)-2-Amino-3-((((R)-2,3-bis(stearoyloxy)propoxy)(hydroxy)phosphoryl)oxy)propanoic acid - 70% |
0 | C42H82NO10P | |
CP006608 |
|
139-05-9 |
Sodium cyclohexylsulfamate - 98% |
0 | C6H12NNAO3S | |
CP000741 |
|
24939-03-5 |
Polyinosinic acid-polycytidylic acid;P I : PC - 50% |
0 | C10H13N4O8P.C9H14N3O8P | |